News
-
-
COMMUNIQUÉ DE PRESSE
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Eurofins bought back 70,000 shares from June 16th to June 20th, 2025, with daily weighted average purchase price of 60.0627. Transaction details available on Eurofins Scientific SE website -
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Déclaration hebdomadaire d'opérations effectuées du 16 au 20 juin 2025
-
COMMUNIQUÉ RÉGLEMENTÉ
Disclosure of transactions in own shares from June 16 to June 20, 2025
-
-
COMMUNIQUÉ DE PRESSE
Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
Biotest AG announces positive phase III trial results for fibrinogen concentrate BT524 in reducing bleeding, with potential regulatory approval in Europe and U.S. pending. Study data to be presented at ISTH 2025 Congress -